Bank of America maintained its Buy rating on Novartis shares.
2 reports, 1 independent
Updated Sep 11
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America maintained its Buy rating on Novartis shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
Novartis
Swiss-American multinational pharmaceutical corporation
Related events
- Bank of America issued a buy rating on the stock of Parabilis Medicines on October 16, 2026.
- Bank of America and Truist Financial reaffirmed and boosted buy ratings and price objectives for Arista Networks.
- Bank of America reported underperformance in earnings and failed to report suspicious transactions.
- Institutional investors are buying BAC shares.
- Bank of America set a buy rating and price target for Penguin Solutions on October 23, 2026.